Cargando…

Impact of GeneXpert MTB/RIF® on treatment initiation and outcomes of RIF-resistant and RIF-susceptible TB patients in Vladimir TB dispensary, Russia

BACKGROUND: The main advantage of GeneXpert MTB/RIF® (Xpert) molecular diagnostic technology is the rapid detection of M.tuberculosis DNA and mutations associated with rifampicin (RIF) resistance for timely initiation of appropriate treatment and, consequently, preventing further transmission of the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ershova, Julia V., Volchenkov, Grigory V., Somova, Tatiana R., Kuznetsova, Tatiana A., Kaunetis, Natalia V., Kaminski, Dorothy, Demikhova, Olga V., Chernousova, Larisa N., Vasilyeva, Irina A., Kerr, Eleanor M., Cegielski, J. Peter, Kurbatova, Ekaterina V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7382080/ https://www.ncbi.nlm.nih.gov/pubmed/32711457 http://dx.doi.org/10.1186/s12879-020-05243-9

Ejemplares similares

Expedited diagnosis of pediatric tuberculosis using Truenat MTB-Rif Dx and GeneXpert MTB/RIF
por: Singh, Urvashi B., et al.
Publicado: (2023)

Diagnostic performance of GeneXpert MTB/RIF in detecting MTB in smear-negative presumptive TB patients
por: Rimal, Raksha, et al.
Publicado: (2022)

Contribution of Xpert(®) MTB/RIF to pediatric TB diagnosis in Mozambique
por: Mutemba, C. M., et al.
Publicado: (2023)

Evaluation of the GeneXpert MTB/RIF in patients with presumptive tuberculous meningitis
por: Metcalf, Tatiana, et al.
Publicado: (2018)

Evaluation of GeneXpert MTB/RIF for Diagnosis of Tuberculous Meningitis
por: Nhu, Nguyen Thi Quynh, et al.
Publicado: (2014)

Epidemiology of Primary Multidrug-Resistant Tuberculosis, Vladimir Region, Russia
por: Ershova, Julia V., et al.
Publicado: (2015)

Using Xpert MTB/RIF
por: Nicol, Mark P., et al.
Publicado: (2013)

Xpert MTB/RIF and Xpert MTB/RIF Ultra for pulmonary tuberculosis and rifampicin resistance in adults
por: Horne, David J, et al.
Publicado: (2019)

Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults
por: Kohli, Mikashmi, et al.
Publicado: (2021)

Xpert MTB/RIF and Xpert MTB/RIF Ultra assays for active tuberculosis and rifampicin resistance in children
por: Kay, Alexander W, et al.
Publicado: (2020)

The Impact and Cost of Scaling up GeneXpert MTB/RIF in South Africa
por: Meyer-Rath, Gesine, et al.
Publicado: (2012)

Role of GeneXpert MTB/Rif Assay in Diagnosing Tuberculosis in Pregnancy and Puerperium
por: Habib, Zaiyad G., et al.
Publicado: (2015)

Evaluation of GeneXpert MTB/RIF assay for direct diagnosis of pulmonary tuberculosis
por: Moussa, Husseiny Sh., et al.
Publicado: (2016)

Evaluation of GeneXpert MTB/RIF system performances in the diagnosis of extrapulmonary tuberculosis
por: Mechal, Youness, et al.
Publicado: (2019)

Diagnostic Performance of Xpert MTB/RIF Ultra Compared with Predecessor Test, Xpert MTB/RIF, in a Low TB Incidence Setting: a Retrospective Service Evaluation
por: Mansfield, Mary, et al.
Publicado: (2022)

Test and Treat TB: a pilot trial of GeneXpert MTB/RIF screening on a mobile HIV testing unit in South Africa
por: Bassett, Ingrid V., et al.
Publicado: (2019)

Diagnosis of paediatric TB using Xpert(®) MTB/RIF Ultra on fresh respiratory samples
por: Sabi, I., et al.
Publicado: (2022)

Comparison of tests done, and tuberculosis cases detected by Xpert® MTB/RIF and Xpert® MTB/RIF-Ultra in Uganda
por: Kakinda, Michael, et al.
Publicado: (2022)

Evaluation of GeneXpert MTB/RIF for detecting Mycobacterium tuberculosis in a hospital in China
por: Tang, Tingyu, et al.
Publicado: (2017)

GeneXpert MTB/RIF assay in the diagnosis of urinary tuberculosis from urine specimens
por: Pang, Yu, et al.
Publicado: (2017)

GeneXpert(®) MTB/RIF assay with transbronchial lung cryobiopsy for Mycobacterium tuberculosis diagnosis
por: Sánchez-Cabral, Olivia, et al.
Publicado: (2020)

Diagnostic accuracy of GeneXpert MTB/RIF assay for detection of tubercular pleural effusion
por: Jain, Jyoti, et al.
Publicado: (2021)

Discordance of the Repeat GeneXpert MTB/RIF Test for Rifampicin Resistance Detection Among Patients Initiating MDR-TB Treatment in Uganda
por: Ssengooba, Willy, et al.
Publicado: (2021)

Comparison of Analytical Sensitivity (Limit of Detection) of Xpert MTB/RIF and Xpert MTB/RIF Ultra for Non-Sputum Specimens
por: Nielsen, Marisa C., et al.
Publicado: (2023)

The effect of sputum quality and volume on the yield of bacteriologically-confirmed TB by Xpert MTB/RIF and smear
por: Zimba, Onani, et al.
Publicado: (2019)

New TB Tools Need to be Affordable in the Private Sector: The Case Study of Xpert MTB/RIF
por: Ponnudurai, Nirros, et al.
Publicado: (2018)

Upfront Xpert MTB/RIF for diagnosis of pediatric TB—Does it work? Experience from India
por: Kalra, Aakshi, et al.
Publicado: (2020)

Empiric treatment of pulmonary TB in the Xpert era: Correspondence of sputum culture, Xpert MTB/RIF, and clinical diagnoses
por: Kendall, Emily A., et al.
Publicado: (2019)

The Application of GeneXpert MTB/RIF for Smear-Negative TB Diagnosis as a Fee-Paying Service at a South Asian General Hospital
por: Shrestha, Poojan, et al.
Publicado: (2015)

An Optimal Diagnostic Strategy for Tuberculosis in Hospitalized HIV-Infected Patients Using GeneXpert MTB/RIF and Alere Determine TB LAM Ag
por: Esmail, Aliasgar, et al.
Publicado: (2020)

Impact of introduction of Xpert MTB/RIF test on tuberculosis (TB) diagnosis in a city with high TB incidence in Brazil
por: Pereira, Giovana Rodrigues, et al.
Publicado: (2018)

Assessment of GeneXpert MTB/RIF Performance by Type and Level of Health-Care Facilities in Nigeria
por: Gidado, Mustapha, et al.
Publicado: (2019)

Challenges with scale-up of GeneXpert MTB/RIF® in Uganda: a health systems perspective
por: Nalugwa, Talemwa, et al.
Publicado: (2020)

Evaluation of the use of GeneXpert MTB/RIF in a zone with high burden of tuberculosis in Thailand
por: Pongpeeradech, Nathakorn, et al.
Publicado: (2022)

Feasibility and Sensitivity of Saliva GeneXpert MTB/RIF Ultra for Tuberculosis Diagnosis in Adults in Uganda
por: Byanyima, Patrick, et al.
Publicado: (2022)

The Value of GeneXpert MTB/RIF for Detection in Tuberculosis: A Bibliometrics-Based Analysis and Review
por: Li, Zhiyi
Publicado: (2022)

Xpert MTB/RIF Ultra versus Xpert MTB/RIF for the diagnosis of tuberculous meningitis: a prospective, randomised, diagnostic accuracy study
por: Donovan, Joseph, et al.
Publicado: (2020)

Role of Xpert MTB/RIF in Bronchoalveolar lavage fluid of sputum-scarce, suspected Pulmonary TB patients
por: Kilaru, Satish Chandra, et al.
Publicado: (2018)

Evaluation of trace calls by Xpert MTB/RIF ultra for clinical management in low TB burden settings
por: Amedeo, Alberto, et al.
Publicado: (2022)

Evaluation of Xpert MTB/RIF for the Diagnosis of Lymphatic Tuberculosis
por: Li, Hou-He, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_bbrgf1m62igk6ee3jv00fc1kpt